Search
Searching Content indexed under Patent by Gowling WLG ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next
 
Title
Country
Organisation
Author
Date
1
Brexit - What Are The Implications For Intellectual Property?
'Brexit' poses considerable challenges for intellectual property law and presents uncertainty as to the involvement of the UK, following its exit from the EU, in existing and proposed international regimes involving EU law.
UK
20 Feb 2018
2
Annual Patents Review 2017 - Overview
When I completed last year's review, noting that it was my nineteenth such report, I quietly had the hope that I would be able to mark my 20th anniversary with something quite significant to report on.
UK
19 Feb 2018
3
Infringement - Annual Patents Review 2017
In previous years I have subdivided this section between "construction" and "infringement". It turns out I was right to do so, but probably not entirely for the right reasons.
UK
19 Feb 2018
4
Validity - Annual Patents Review 2017
This is the Validity chapter of Gordon Harris' Annual Patents Review 2017.
UK
19 Feb 2018
5
Competition Law, Settlement And Licensing - Annual Patents Review 2017
This is the Competition Law, Settlement and Licensing chapter of Gordon Harris' Annual Patents Review 2017.
UK
19 Feb 2018
6
Technical Matters And Procedure - Annual Patents Review 2017
This is the Technical Matters and Procedure chapter of Gordon Harris' Annual Patents Review 2017.
UK
19 Feb 2018
7
From TPP To CPTPP: Suspensions To IP Provisions
The negotiations thus far contemplate significant changes to intellectual property chapter of the original TPP.
Canada
16 Feb 2018
8
Top 10 Differences In Patent Litigation In Canada And The U.S.
Patent owners are increasingly looking outside the United States in order to enforce their patent rights.
Worldwide
25 Jan 2018
9
Canadian Patent Law: 2017 Year In Review
2017 was a busy year in Canadian patent law. The contentious Promise Doctrine was rejected by the Supreme Court of Canada in AstraZeneca v Apotex, the largest monetary judgment ...
Canada
5 Jan 2018
10
The Skinny On Skinny Labels
In a recent decision of Federal Court (Bristol-Myers Squibb Canada v Apotex Inc., 2017 FC 1061), Justice Lafrenière dismissed the prohibition proceeding ...
Canada
27 Dec 2017
11
New Patented Medicines Prices Review Board (PMPRB) Regulations Open For Comment
The Canadian government recently published its proposed Regulations Amending the Patented Medicines Regulations (the "Regulations") for coming into force January 1, 2019.
Canada
15 Dec 2017
12
Invention Pertaining To Medicine Not Carte Blanche For PMPRB Jurisdiction
On November 9, 2017, the Federal Court released a decision in which it overturned the decision of a Panel of the Patented Medicine Prices Review Board ...
Canada
15 Dec 2017
13
Mind The Actavis v Eli Lilly Gap Please!
Following the Supreme Court's decision in Actavis v Lilly, is there a gap between the interpretation of a patent claim for validity purposes and its reach for infringement purposes?
Canada
29 Nov 2017
14
London Design Festival: Design Protection - Hindsight Giving Insight
Welcome to this our fifth annual event as part of the London Design Festival.
UK
10 Nov 2017
15
PMPRB Decision Creates Uncertainty For Patentees
On September 27, 2017, a two-member Hearing Panel of the Patented Medicine Price Review Board (PMPRB) ruled that the ultra-rare disease drug Soliris® (eculizumab), manufactured by Alexion Pharmaceuticals Inc. (Alexion), was "excessively priced." The Panel ordered both a reduction of the price of Soliris going forward and required Alexion to pay past "excessive" revenues.
Canada
8 Nov 2017
16
Singapore High Court Has No Original Jurisdiction To Revoke A Patent
For years, defendants in patent infringement proceedings have brought counterclaims for revocation of the patent. However, a recent High Court judgment indicates that this is no longer possible.
Singapore
31 Oct 2017
17
Defects In Pre-Patent Issue Process Do Not Render A Patent Void
In Apotex Inc. v Pfizer Inc. et al, 2017 FCA 201, the Federal Court of Appeal refused to void a patent based on an administrative error made during the prosecution of the patent application...
Canada
25 Oct 2017
18
Actavis v Eli Lilly: The Doctrine Of Equivalents In The UK, France And Germany
In view of the UK Supreme Court's judgment in Actavis v Eli Lilly, when will an 'equivalent' infringe as an immaterial variant?
Worldwide
11 Oct 2017
19
UK Rewrites Its Law Prohibiting Threats Of Legal Proceedings For IP Infringement
The Intellectual Property (Unjustified Threats) Act 2017 (the "Act") entered into force on 1 October 2017, introducing changes to the law in the UK regarding threats of intellectual property proceedings.
UK
9 Oct 2017
20
Actavis V Eli Lilly - What Is "Normal Interpretation"?
In a landmark decision (Actavis v Eli Lilly), the UK Supreme Court has re-steered the law of patent infringement in the UK, stating that there is a doctrine of equivalents.
UK
2 Oct 2017
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next